LEXEO Therapeutics Funding: $185M Raised, Series B (2021)
LEXEO Therapeutics is based in New York City, New York. It has raised $185M in total funding. Latest round: Series B.
LEXEO Therapeutics funding overview
LEXEO Therapeutics is based in New York City, New York. LEXEO Therapeutics has raised $185M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2021. The round record for LEXEO Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include D1 Capital Partners, Eventide Asset Management, CAM Capital, Verition Fund Management, Laurion Capital Management, Gray’s Creek Capital Partners and 8 others. 14 distinct backers are named across the disclosed rounds.
LEXEO Therapeutics at a glance
Total raised
$185M
Latest round
Series B
Latest round date
September 2021
Headquarters
New York City, New York
Notable investors
D1 Capital Partners, Eventide Asset Management, CAM Capital, Verition Fund Management, Laurion Capital Management, Gray’s Creek Capital Partners, Longitude Capital, Omega Funds
Frequently asked about LEXEO Therapeutics funding
How much has LEXEO Therapeutics raised?
LEXEO Therapeutics has raised $185M in total disclosed funding across the rounds on record.
Who has invested in LEXEO Therapeutics?
D1 Capital Partners, Eventide Asset Management, CAM Capital, Verition Fund Management, Laurion Capital Management, Gray’s Creek Capital Partners are named among the investors backing LEXEO Therapeutics.
What was the latest LEXEO Therapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2021.
Where is LEXEO Therapeutics based?
LEXEO Therapeutics is based in New York City, New York.
When did LEXEO Therapeutics last raise?
The last disclosed LEXEO Therapeutics round closed in September 2021 at Series B.
Round data for LEXEO Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New York City and backer lists below.
